197 related articles for article (PubMed ID: 2653745)
1. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
2. Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Autonomic brake index and heart-rate variation.
Rabinowe SL; Brown FM; Watts M; Smith AM
Diabetes Care; 1990 Oct; 13(10):1084-8. PubMed ID: 1698597
[TBL] [Abstract][Full Text] [Related]
3. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
Brown FM; Kamalesh M; Adri MN; Rabinowe SL
Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients.
Schsnell O; Muhr D; Dresel S; Tatsch K; Ziegler AG; Haslbeck M; Standl E
Diabetologia; 1996 Aug; 39(8):970-5. PubMed ID: 8858220
[TBL] [Abstract][Full Text] [Related]
5. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy.
Muhr D; Mollenhauer U; Ziegler AG; Haslbeck M; Standl E; Schnell O
Diabetes Care; 1997 Jun; 20(6):1009-12. PubMed ID: 9167116
[TBL] [Abstract][Full Text] [Related]
7. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
[TBL] [Abstract][Full Text] [Related]
8. Anti-sympathetic nervous system autoantibodies. Diminished catecholamines with orthostasis.
Brown FM; Brink SJ; Freeman R; Rabinowe SL
Diabetes; 1989 Jul; 38(7):938-41. PubMed ID: 2737366
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
10. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
11. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
12. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus.
Herskowitz RD; Wolfsdorf JI; Ricker AT; Vardi P; Dib S; Soeldner JS; Eisenbarth GS
Diabetes Res; 1988 Dec; 9(4):161-7. PubMed ID: 3073902
[TBL] [Abstract][Full Text] [Related]
13. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.
Muñoz A; Gallart T; Usac EF; Fernández-Alvarez J; Viñas O; Somoza N; Barceló J; Gomis R
Diabetologia; 1995 Jan; 38(1):62-72. PubMed ID: 7538087
[TBL] [Abstract][Full Text] [Related]
14. Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.
Karjalainen J; Knip M; Mustonen A; Ilonen J; Akerblom HK
Diabetes; 1986 May; 35(5):620-2. PubMed ID: 3514336
[TBL] [Abstract][Full Text] [Related]
15. Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus.
Brown FM; Vinik AI; Ganda OP; Adri MN; Rabinowe SL
Horm Metab Res; 1989 Aug; 21(8):434-7. PubMed ID: 2676819
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
[TBL] [Abstract][Full Text] [Related]
17. Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children.
Gerling I; Baekkeskov S; Lernmark A
J Immunol; 1986 Dec; 137(12):3782-5. PubMed ID: 3537124
[TBL] [Abstract][Full Text] [Related]
18. Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes.
Bleich D; Jackson RA; Soeldner JS; Eisenbarth GS
Diabetes Care; 1990 Feb; 13(2):111-8. PubMed ID: 2190768
[TBL] [Abstract][Full Text] [Related]
19. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.
Harrison LC; Chu SX; DeAizpurua HJ; Graham M; Honeyman MC; Colman PG
J Clin Invest; 1992 Apr; 89(4):1161-5. PubMed ID: 1556180
[TBL] [Abstract][Full Text] [Related]
20. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.
Gianani R; Pugliese A; Bonner-Weir S; Shiffrin AJ; Soeldner JS; Erlich H; Awdeh Z; Alper CA; Jackson RA; Eisenbarth GS
Diabetes; 1992 Mar; 41(3):347-53. PubMed ID: 1551494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
